These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17696489)

  • 1. Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds.
    Anders MW
    Chem Res Toxicol; 2008 Jan; 21(1):145-59. PubMed ID: 17696489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione-dependent bioactivation of haloalkanes and haloalkenes.
    Anders MW
    Drug Metab Rev; 2004 Oct; 36(3-4):583-94. PubMed ID: 15554237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione-dependent bioactivation of xenobiotics: implications for mutagenicity and carcinogenicity.
    Anders MW
    Princess Takamatsu Symp; 1990; 21():89-99. PubMed ID: 2134693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-dependent bioactivation of haloalkenes.
    Anders MW; Dekant W
    Annu Rev Pharmacol Toxicol; 1998; 38():501-37. PubMed ID: 9597164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites.
    Anders MW; Lash L; Dekant W; Elfarra AA; Dohn DR
    Crit Rev Toxicol; 1988; 18(4):311-41. PubMed ID: 3288445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-dependent toxicity.
    Anders MW; Dekant W; Vamvakas S
    Xenobiotica; 1992; 22(9-10):1135-45. PubMed ID: 1441604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate beta-lyase.
    Dekant W; Vamvakas S; Anders MW
    Drug Metab Rev; 1989; 20(1):43-83. PubMed ID: 2653763
    [No Abstract]   [Full Text] [Related]  

  • 8. Cysteine conjugate beta-lyase-catalyzed bioactivation of bromine-containing cysteine S-conjugates: stoichiometry and formation of 2,2-difluoro-3-halothiiranes.
    Finkelstein MB; Dekant W; Anders MW
    Chem Res Toxicol; 1996; 9(1):227-31. PubMed ID: 8924595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A).
    Iyer RA; Anders MW
    Chem Res Toxicol; 1997 Jul; 10(7):811-9. PubMed ID: 9250416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mercapturic acid pathway.
    Hanna PE; Anders MW
    Crit Rev Toxicol; 2019 Nov; 49(10):819-929. PubMed ID: 31944156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of coumarin in rat olfactory mucosal microsomes: Detection of protein covalent binding and identification of reactive intermediates through analysis of glutathione adducts.
    Zhuo X; Zhao W; Zheng J; Humphreys WG; Shu YZ; Zhu M
    Chem Biol Interact; 2009 Oct; 181(2):227-35. PubMed ID: 19576871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-dependent bioactivation of xenobiotics.
    Dekant W; Vamvakas S
    Xenobiotica; 1993 Aug; 23(8):873-87. PubMed ID: 8284943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity.
    Park BK; Laverty H; Srivastava A; Antoine DJ; Naisbitt D; Williams DP
    Chem Biol Interact; 2011 Jun; 192(1-2):30-6. PubMed ID: 20846520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical toxicology of chemical teratogenesis.
    Wells PG; Winn LM
    Crit Rev Biochem Mol Biol; 1996 Feb; 31(1):1-40. PubMed ID: 8744954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione conjugate mediated toxicities.
    Monks TJ; Anders MW; Dekant W; Stevens JL; Lau SS; van Bladeren PJ
    Toxicol Appl Pharmacol; 1990 Oct; 106(1):1-19. PubMed ID: 2251674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine.
    Wen B; Ma L; Rodrigues AD; Zhu M
    Drug Metab Dispos; 2008 May; 36(5):841-50. PubMed ID: 18238857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity of the glutathione and cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3, 3-pentafluoro-1-propene (Compound A) in male Fischer 344 rats.
    Iyer RA; Baggs RB; Anders MW
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1544-51. PubMed ID: 9400032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.
    Masubuchi N; Makino C; Murayama N
    Chem Res Toxicol; 2007 Mar; 20(3):455-64. PubMed ID: 17309281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical-induced nephrotoxicity mediated by glutathione S-conjugate formation.
    Dekant W
    Toxicol Lett; 2001 Oct; 124(1-3):21-36. PubMed ID: 11684355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.